Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 31, 2022
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round TableChristophe Leclercq, Henning Witt, Gerhard Hindricks, et al.
JACC. Advances|April 26, 2025
Very Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Ischemic and Nonischemic CardiomyopathyAnshul R Gupta, Suganya Karikalan, Nishanth Katukuri, et al.
Computational Toxicology (Amsterdam, Netherlands)|February 26, 2026
Development of the toxicity values database, ToxValDB: A curated resource for experimental and derived human health-relevant toxicity dataJonathan T Wall, Risa R Sayre, Doris Smith, et al.
Environment International|December 30, 2024
Private, public, and bottled drinking water: Shared contaminant-mixture exposures and effects challengePaul M Bradley, Kristin M Romanok, Kelly L Smalling, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 30, 2024
Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access StudiesVenkata Sagi, Francis Murgatroyd, Lucas V A Boersma, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 19, 2025
Integration of new approach methods for the assessment of data-poor chemicalsKatie Paul Friedman, Russell S Thomas, John F Wambaugh, et al.
Chemical Research in Toxicology|July 22, 2025
Applying New Approach Methods for Toxicokinetics for Chemical Risk AssessmentJohn F Wambaugh, Katie Paul Friedman, Marc A Beal, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 19, 2019
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based PrioritizationKatie Paul Friedman, Matthew Gagne, Lit-Hsin Loo, et al.
Pageof 13